Tetrahydrocannabinol cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity newest evidence.
Proceedings of an Almirall-sponsored satellite symposium held at the 34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Berlin, Germany, 10 October 2018.